Summary
After acid gelchromatography cerebrospinal fluid and serum levels of immunoreactive insulin-like growth factor 1 and 2 (IGF-1 and IGF-2) were determined in patients with dementia of the Alzheimer type (AD) and in healthy subjects. The AD CSF levels of immunoreactive IGF-1 did not differ from the subjects but the levels of immunoreactive IGF-2 was significantly elevated in both serum and CSF in the AD patient group. Additionally immunoreactive IGF-1 in AD serum was found to be significantly elevated. To characterize the CSF IGF binding protein activity (IGFBP), ligand blotting was performed on whole CSF from AD patients and subjects. The results demonstrate two major forms of IGFBP in CSF with approximate molecular weights of 33 KDa and 30 KDa. The two IGFBP forms are suggested to represent IGFBP-2 and IGFBP-6. A highly significant increase in both the IGFBPs was observed in the CSF of the AD patients compared to the healthy subjects.
Similar content being viewed by others
References
Åsberg M, Montgomery SA, Perris C, Schalling D, Sedvall GA (1978) Comprehensive psychopathological rating scale. Acta Psychiatr Scand [Suppl] 271: 5–27
Bang P, Brandt J, Degerblad M, Enberg G, Kaijser L, Thoren M, Hall K (1990) Exercise-induced changes in insulin-like growth factors and their low molecular weight binding proteins in healthy subjects and in patients with growth hormone deficiency. Eur J Clin Invest 20: 285–292
Brismar K, Gutniak M, Povoa G, Werner S, Hall K (1988) Insulin regulates the 33 KDa IGF binding protein in patients with diabetes mellitus. J Endocrinol Invest 11: 599–602
Brismar K, Grill V, Efendic S, Hall K (1991) The insulin-like growth factor binding protein-1 in low and high insulin responders before and during dexamethasone treatment. Metabolism 20: 728–732
Bucht G, Adolfsson R, Lithner F, Winblad B (1983) Changes in blood glucose and insulin secretion in patients with senile dementia of Alzheimer type. Acta Med Scand 213: 387–392
Carlsson-Skwirut C, Jörnvall H, Holmgren A, Andersson C, Bergman T, Lundquist G, Sjögren B, Sara VR (1986) Isolation and characterization of variant IGF-1 as well as IGF-2 from adult human brain. FEBS Lett 201: 46–50
Conover C, Powell DR (1991) Insulin-like growth factor (IGF)-binding protein-3 blocks IGF-1-induced receptor down-regulation and cell desensitization in cultured bovine fibroblasts. Endocrinology 129: 710–716
Dahmer MK, Perlman RL (1988) Bovine chromaffin cells have insulin-like growth factor-1 (IGF-1) receptors: IGF enhances catecholamine secretion. J Neurochem 51: 321–323
Dropp SLS, Brinkman A, Kotrleve DJ, Groffen CAH, Schuller A, Zwarthorff EC (1991) The evolution of the insulin-like growth factor binding protein family. In: Martin Spencer E (ed) Modern concept of insulin-like growth factors. Elsevier, Amsterdam New York Tokyo London, pp 311–328
Enberg G, Tham A, Sara VR (1985) The influence of purified somatomedins and insulin on foetal rat brain DNA synthesis in vitro. Acta Physiol Scand 125: 305–308
Erkinjuntti T, Laaksonen R, Sulkava R, Syrjäälinen R, Palo J (1986) Neuropsychological differentiation between normal aging, Alzheimer's disease and vascular dementia. Acta Neurol Scand 74: 393–403
Fernyhough P, Mill JF, Roberts JL, Ishii DN (1989) Stabilization of tubulin mRNAs by insulin and insulin-like growth factor 1 during neurite formation. Mol Brain Res 6: 109–120
Folstein MF, Folstein SE, McHugh PR (1975). “Mini mental state”. A practical method for grading the cognitive state of patients for the clinician. J Psychiatr Res 12: 189–198
Fujisawa Y, Sasaki K, Akiyama K (1991) Increased insulin levels after OGTT load in peripheral blood and cerebrospinal fluid of patients with dementia of Alzheimer type. Biol Psychiatry 30: 1219–1228
Gammeltoft S, Haselbacher GK, Humbel RE, Fehlmann M, Van Obberghen E (1985) Two types of receptors for insuline-like growth factors in mammalian brain. EMBO J 4: 3407–3412
Hall K, Lundin G, Povoa G (1988) Serum levels of the low molecular weight form of insulin-like growth factor binding protein in healthy subjects and in patients with growth hormone deficiency, acromegaly and anorexia nervosa. Acta Endocrinol 118: 321–326
Hall K, Johansson BL, Povoa G, Thalme B (1989) Serum levels of insulin-like growth factor (IGF) I, II and IGF binding protein in diabetic adolescents treated with continuous subcutaneous insulin infusion. J Int Med 225: 273–278
Hardy J, Adolfsson R, Alufuzoff I, Bucht G, Marcusson J, Nyberg P, Perdahl E, Wester P, Windblad B (1985) Transmitter deficits in Alzheimer's disease. Neurochem Int 7: 545–563
Haselbacher G, Humbel R (1982) Evidence for two species of insulin-like growth factor II (IGF II and “big” IGF II) in human spinal fluid. Endocrinology 110: 1822–1824
Hefti F, Will B (1987) Nerve growth factor is a neurotrophic factor for forbrain cholinergic neurons; implications for Alzheimer's disease. J Neural Transm [Suppl 24]: 309–315
Hefti F, Hartikka J, Knusel B (1989) Function of neurotrophic factors in the adult and aging brain and their possible use in the treatment of neurodegenerative diseases. Neurobiol Aging 10: 515–533
Hossenlopp P, Seurin D, Segovia-Quinson B, Hardouin S, Binoux M (1986) Analysis of serum insulin-like growth factor binding proteins using western blotting: use of the method for titration of the binding proteins and competitive binding studies. Ann Biochem 154: 138–143
Husain MM, Nemeroff CB (1990) Neuropeptides and Alzheimer's disease. JAGS 38: 918–925
Hynes MA, Brooks PJ, Van Wyk JJ, Lund PK (1988) Insulin-like growth factor II messenger ribonucleic acids are synthesized in the choroid plexus of the rat brain. Mol Endocrinol 2: 47–54
Lesniak MA, Hill JM, Kiess W, Rojeski M, Pert C, Roth J (1988) Receptors for insulin-like growth factors I and II: autoradiographic localization in rat brain and comparison to receptors for insulin. Endocrinology 123: 2089–2099
McCusker RH, Busby WH, Dehoff MH, Camacho-Hubner C, Clemmons DR (1991) Insulin-like growth factor (IGF) binding to cell monolayers is directly modulated by the addition of IGF-binding proteins. Endocrinology 129: 939–949
McKhann G, Drachman D, Folstein M, Katzman R, Price D, Stadlan EM (1984) Clinical diagnosis of Alzheimer's disease: report of the NINCDS-ADRDA work group under the auspices of Department of Health and Human services task force on Alzheimer's disease. Neurology 34: 939–944
Nilsson L, Sara VR, Nordberg A (1988) Insulin-like growth factor 1 stimulates the release of acetylcholine from rat cortical slices. Neurosci Lett 88: 221–226
Ocrant I, Fay CT, Parmelee JT (1990) Characterization of insulin-like growth factor binding proteins produced in the rat central nervous system. Endocrinology 127: 1260–1267
Olson Jr J, Shiverick KT, Ogilvie S, Buhi WC, Raizada MK (1991) Developmental expression of rat insulin-like growth factor binding protein-2 by astrocytic glial cells in culture. Endocrinology 129: 1066–1074
Recio-Pinto E, Ishii DN (1984) Effects of insulin, insulin-like growth factor-II and nerve growth factor on neurite outgrowth in cultured human neuroblastoma cells. Brain Res 302: 323–334
Reitan RM (1958) Validity of the trail making test as an indicator of organic brain damage. Percept Mot Skills 8: 271–276
Roghani M, Lassarre C, Zapf J, Povoa G, Binoux M (1991) Two insulin-like growth factor (IGF)-binding proteins are responsible for the selective affinity for IGF-II of cerbrospinal fluid binding proteins. J Clin Endocrinol Metab 73: 658–666
Sandberg A-C, Engberg C, Lake M, V Holst H, Sara VR (1988) The expression of insulin-like growth factor 1 and insulin-like growth factor II genes in the human fetal and adult brain and in glioma. Neurosci Lett 93: 114–119
Sara VR, Hall K (1990) Insulin-like growth factors and their binding proteins. Physiol Rev 70: 591–614
Sara VR, Hall K, Enzell K, Gardner A, Morawski R, Wetterberg (1982) Somatomedins in aging and in dementia of the Alzheimer type. Neurobiol Aging 3: 117–120
Sara VR, Carlsson-Skwirut C, Andersson C, Hall E, Sjögren B, Holmgren A, Jörnvall H (1986) Characterization of somatomedins from human fetal brain: identification of a variant form of insulin-like growth factor I. Proc Natl Acad Sci 83: 4904–4907
Selkoe DJ (1991) The molecular pathology of Alzheimer's disease. Neuron 6: 487–498
Stylianopoulou F, Herbert J, Soares MB, Efstratiadis A (1988) Expression of the insulin-like growth factor II gene in the choroid plexus and the leptomeninges of the adult rat central nervous system. Proc Natl Acad Sci 85: 141–145
Tham A, Sparring K, Bowen D, Wetterberg L, Sara VR (1988) Insulin-like growth factors and somatomedin B in the cerebrospinal fluid of patients with dementia of the Alzheimer type. Acta Psychiatr Scand 77: 719–723
Tseng LY-H, Brown AL, Yang YW-H, Romanus JA, Orlowski CC, Taylor T, Rechler MM (1989) The fetal rat binding protein for insulin-like growth factor is expressed in the choroid plexus and cerebrospinal fluid of adult rats. Mol Endocrinol 3: 1559–1568
Wechsler DA (1945) A standardized memory scale for clinical use. J Psychol 19: 87–95
Wechsler DA (1981) Wechsler adult intelligence scale-revised manual. Psychological Corporation, New York
Weingartner H, Grafman J, Boutelle W, Kay W, Martin PR (1983) Forms of memory failure. Science 122: 380–382
Werther GA, Abate M, Hogg A, Oldfield CB, Hards D, Hudson P, Power B, Freed K, Herington AC (1990) Localization of insulin-like growth factor-I mRNA in rat brain by in situ hybridization-relationship to IGF-1 receptors. Mol Endocrinol 4: 773–778
Wood TL, Brown AL, Rechler MM, Pintar JE (1990) The expression pattern of an insulin-like growth factor (IGF)-binding protein gene is distinct from IGF-II in the midgestational rat embryo. Mol Endocrinol 4: 1257–1263
Yamaguchi F, Itano T, Mizobuchi M, Miyamoto O, Janjua NA, Matsui H, Tokuda M, Ohmoto T, Hosokawa K, Hatase O (1990) Insulin-like growth factor 1 (IGF-1) distribution in the tisue and extracellular compartment in different regions of rat brain. Brain Res 533: 344–347
Author information
Authors and Affiliations
Rights and permissions
About this article
Cite this article
Tham, A., Nordberg, A., Grissom, F.E. et al. Insulin-like growth factors and insulin-like growth factor binding proteins in cerebrospinal fluid and serum of patients with dementia of the Alzheimer type. J Neural Transm Gen Sect 5, 165–176 (1993). https://doi.org/10.1007/BF02257671
Received:
Accepted:
Issue Date:
DOI: https://doi.org/10.1007/BF02257671